Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir + PegIFN/RBV in HCV Genotype 1
NCT00874770Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of daclatasvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Jun 2009; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00874770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874770.